HKSE - Delayed Quote HKD

Sinopharm Group Co. Ltd. (1099.HK)

21.550 -0.200 (-0.92%)
At close: 4:08 PM GMT+8
Loading Chart for 1099.HK
DELL
  • Previous Close 21.750
  • Open 21.750
  • Bid 21.550 x --
  • Ask 21.600 x --
  • Day's Range 21.350 - 22.150
  • 52 Week Range 17.440 - 28.450
  • Volume 8,013,009
  • Avg. Volume 5,115,635
  • Market Cap (intraday) 67.25B
  • Beta (5Y Monthly) 0.83
  • PE Ratio (TTM) 6.86
  • EPS (TTM) 3.140
  • Earnings Date Apr 26, 2024
  • Forward Dividend & Yield 0.94 (4.33%)
  • Ex-Dividend Date Jun 17, 2024
  • 1y Target Est 27.58

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

www.sinopharmgroup.com.cn

115,959

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1099.HK

Performance Overview: 1099.HK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

1099.HK
5.38%
HANG SENG INDEX
3.54%

1-Year Return

1099.HK
16.85%
HANG SENG INDEX
10.03%

3-Year Return

1099.HK
1.29%
HANG SENG INDEX
39.30%

5-Year Return

1099.HK
17.89%
HANG SENG INDEX
40.27%

Compare To: 1099.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1099.HK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    67.87B

  • Enterprise Value

    78.66B

  • Trailing P/E

    6.94

  • Forward P/E

    6.62

  • PEG Ratio (5yr expected)

    2.48

  • Price/Sales (ttm)

    0.11

  • Price/Book (mrq)

    0.84

  • Enterprise Value/Revenue

    0.13

  • Enterprise Value/EBITDA

    3.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.52%

  • Return on Assets (ttm)

    3.73%

  • Return on Equity (ttm)

    13.03%

  • Revenue (ttm)

    596.57B

  • Net Income Avi to Common (ttm)

    9.05B

  • Diluted EPS (ttm)

    3.140

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    63.81B

  • Total Debt/Equity (mrq)

    61.32%

  • Levered Free Cash Flow (ttm)

    6.64B

Research Analysis: 1099.HK

Analyst Price Targets

22.26
27.58 Average
21.550 Current
33.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: 1099.HK

People Also Watch